Phase II Randomized Trial of Pazopanib Vs. Local Therapy for Renal Cell Carcinoma Patients With Limited Metastases
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 21 Jun 2017 Planned primary completion date changed from 1 Dec 2019 to 31 Dec 2020.
- 21 Jun 2017 Planned initiation date changed from 1 Nov 2016 to 15 Jul 2017.
- 09 Nov 2016 New trial record